Skip to main content
. 2023 Sep 29;18(1):E32–E36. doi: 10.5489/cuaj.8438

Table 2.

Adverse events of adjuvant chemotherapy

GC (n=12) GCa (n=24) Total (n=36)
Any grade Grade ≤3 Any grade Grade ≤3 Any grade Grade ≤3

Appetite loss 2 (16.7) 0 (0) 1 (4.2) 0 (0) 3 (8.3) 0 (0)

Nausea 0 (0) 0 (0) 4 (16.7) 0 (0) 4 (11.2) 0 (0)

General fatigue 0 (0) 0 (0) 3 (12.5) 0 (0) 3 (8.3) 0 (0)

Neutropenia 3 (25.0) 1 (8.3) 15 (62.5) 6 (25.0) 18 (50.0) 7 (19.5)

Thrombocytopenia 5 (41.7) 5 (41.7) 14 (58.3) 12 (50.0) 19 (52.8) 17 (47.2)

Eruption 1 (8.3) 0 (0) 1 (4.2) 0 (0) 2 (5.6) 0 (0)

Orthostatic hypotension 0 (0) 0 (0) 1 (4.2) 0 (0) 1 (2.8) 0 (0)

Diarrhea 0 (0) 0 (0) 1 (4.2) 0 (0) 1 (2.8) 0 (0)

GC: gemcitabine/cisplatin; GCa: gemcitabine/carboplatin.